Gary A. Pestano

1.5k total citations
41 papers, 1.0k citations indexed

About

Gary A. Pestano is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gary A. Pestano has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Cancer Research and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gary A. Pestano's work include Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (7 papers) and HIV Research and Treatment (6 papers). Gary A. Pestano is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Lung Cancer Treatments and Mutations (7 papers) and HIV Research and Treatment (6 papers). Gary A. Pestano collaborates with scholars based in United States, Germany and Hong Kong. Gary A. Pestano's co-authors include Harvey Cantor, Georg F. Weber, Ubaradka G. Sathyanarayana, Mark A. Rubin, Raymond B. Nagle, Dea Nagy, Ashutosh Tewari, Alistair Noble, Francesca Demichelis and Theresa Y. MacDonald and has published in prestigious journals such as Science, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Gary A. Pestano

39 papers receiving 1.0k citations

Peers

Countries citing papers authored by Gary A. Pestano

Since Specialization

Citations

This map shows the geographic impact of Gary A. Pestano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary A. Pestano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary A. Pestano more than expected).

Fields of papers citing papers by Gary A. Pestano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary A. Pestano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary A. Pestano. The network helps show where Gary A. Pestano may publish in the future.

Co-authorship network of co-authors of Gary A. Pestano

This figure shows the co-authorship network connecting the top 25 collaborators of Gary A. Pestano. A scholar is included among the top collaborators of Gary A. Pestano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary A. Pestano. Gary A. Pestano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages 2024 ·Diagnostics ·(unknown), (unknown), Frederick L. Baehner, James Chen, Carin R. Espenschied, David Fabrizio, (unknown), (unknown), Justin Guinney, Greg Jones, (unknown), Michael S. Nahorski, Melanie R. Palomares, Gary A. Pestano, Mark Sausen, Alain D. Silk, Nicole Zhang, Zhihong Zhang, Mark Stewart, Jeff Allen	1
2	Comparison of antibody response durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 vaccines in healthcare workers 2022 ·International Journal of Infectious Diseases ·(unknown), Daniel Freilich, Jennifer Victory, Nicole Krupa, Melissa Scribani, Paul Jenkins, (unknown), (unknown), (unknown), (unknown), Valerie Bush, Laura J. Peek, Gary A. Pestano, Anne Gadomski	6
3	Development of a TCR beta repertoire assay for profiling liquid biopsies from NSCLC donors 2020 ·Cancer Drug Resistance ·Leisa Jackson, B.A. Tjoa, Hestia Mellert, Gary A. Pestano	3
4	Longitudinal monitoring for the emergence of epidermal growth factor C797S resistance mutations in non-small cell lung cancer using blood-based droplet digital PCR 2019 ·Cancer Drug Resistance ·Mark Bowling, Hyder Arastu, (unknown), Leisa Jackson, Scott Thurston, (unknown), Hestia Mellert, Gary A. Pestano, Paul Walker	4
5	A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction 2018 ·Journal of Visualized Experiments ·Hestia Mellert, (unknown), Leisa Jackson, Gary A. Pestano	4
6	Development and Clinical Utility of a Blood-Based Test Service for the Rapid Identification of Actionable Mutations in Non–Small Cell Lung Carcinoma 2017 ·Journal of Molecular Diagnostics ·Hestia Mellert, Trudi Foreman, Leisa Jackson, Dianna Maar, Scott Thurston, (unknown), (unknown), Samantha Cooper, Nicholas Dupuis, Ubaradka G. Sathyanarayana, (unknown), (unknown), Dawne N. Shelton, (unknown), Gary A. Pestano	29
7	PTEN Loss Is Associated with Worse Outcome in HER2 -Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance 2015 ·Clinical Cancer Research ·Howard M. Stern, Humphrey Gardner, Tomasz Burzykowski, Wafaa Elatre, Carol O’Brien, Mark R. Lackner, Gary A. Pestano, Angela Santiago, Ivonne Villalobos, W. Eiermann, Tadeusz Pieńkowski, Miguel Martín, Nicholas J. Robert, John Crown, Paolo Nucíforo, Valerie Bée, John R. Mackey, Dennis J. Slamon, Michael F. Press	57
8	Novel dual-color immunohistochemical methods for detecting ERG–PTEN and ERG–SPINK1 status in prostate carcinoma 2013 ·Modern Pathology ·Ritu Bhalla, Lakshmi P. Kunju, Scott A. Tomlins, (unknown), Connie C. Cortez, Shannon Carskadon, Javed Siddiqui, Kyung Park, Juan Miguel Mosquera, Gary A. Pestano, Mark A. Rubin, Arul M. Chinnaiyan, Nallasivam Palanisamy	35
9	Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer 2010 ·Neoplasia ·Kyung Park, Scott A. Tomlins, Kumaran Mudaliar, Ya-Lin Chiu, Raquel Esgueva, Rohit Mehra, (unknown), Sooryanarayana Varambally, J. Chad Brenner, Theresa Y. MacDonald, Abhishek Srivastava, Ashutosh Tewari, Ubaradka G. Sathyanarayana, Dea Nagy, Gary A. Pestano, Lakshmi P. Kunju, Francesca Demichelis, Arul M. Chinnaiyan, Mark A. Rubin	257
10	Testing mutual exclusivity of ETS rearranged prostate cancer 2010 ·Laboratory Investigation ·Maria A. Svensson, Christopher J. Lafargue, Theresa Y. MacDonald, Dorothee Pflueger, Naoki Kitabayashi, (unknown), Karl Garsha, Ubaradka G. Sathyanarayana, (unknown), C. Steven Yun, Dea Nagy, (unknown), Gary A. Pestano, Ashutosh Tewari, Francesca Demichelis, Mark A. Rubin	58
11	Human Cell Surface Receptors as Molecular Imaging Candidates for Metastatic Prostate Cancer 2009 ·PubMed ·Isis C. Sroka, Gerald D. Pond, Raymond B. Nagle, Frank Porreca, Tamara King, Gary A. Pestano, Bernard W. Futscher, Jaime M.C. Gard, (unknown), Ubaradka G. Sathyanarayana, Anne E. Cress	7
12	Osteopontin‐c is a selective marker of breast cancer 2007 ·International Journal of Cancer ·M. B. Mirza, Elizabeth Shaughnessy, John K. Hurley, (unknown), Gary A. Pestano, Bin He, Georg F. Weber	111
13	Expression of mTOR signaling pathway markers in prostate cancer progression 2006 ·The Prostate ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gary A. Pestano, Raymond B. Nagle	149
14	Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T-cell responses 2003 ·Cancer Immunology Immunotherapy ·Yaling Zhou, Julie A. McEarchern, Edward D. Howard, Gary A. Pestano, Michael L. Salgaller, Marnix L. Bosch	8
15	Fas-Dependent Elimination of Nonselected CD8 Cells and lpr Disease 2002 ·The Journal of Immunology ·Linda A. Trimble, (unknown), Gary A. Pestano, John Daley, Harvey Cantor	11
16	A single point mutation in HIV-1 V3 loop alters the immunogenic properties of rgp120 2000 ·Archives of Virology ·(unknown), Gary A. Pestano, (unknown), Adam Hasan, Mark Pezzano, (unknown), (unknown), J. Guyden, William Boto	8
17	Suppression of Immune Responses by CD8 Cells. I. Superantigen-Activated CD8 Cells Induce Unidirectional Fas-Mediated Apoptosis of Antigen-Activated CD4 Cells 1998 ·The Journal of Immunology ·Alistair Noble, Gary A. Pestano, Harvey Cantor	52
18	Seroreactivity of Analogous Antigenic Epitopes in Glycoprotein 120 Expressed in HIV-1 Subtypes A, B, C, and D 1995 ·AIDS Research and Human Retroviruses ·Gary A. Pestano, (unknown), Alexander I. Spira, (unknown), (unknown), Nelson K. Sewankambo, Lawrence S. Brown, David D. Ho, William Boto	10
19	Independent divergences in the CD4 binding site and V3 loop encoded in two seroprevalent Ugandan HIV-1 clinical isolates. 1993 ·PubMed ·Gary A. Pestano, A. M. Prince, J. Guyden, James M. Ntambi, (unknown), William Boto	4
20	Phylogenetic and Serological Characterization of Two Ugandan HIV-1 Isolates 1993 ·AIDS Research and Human Retroviruses ·(unknown), Gary A. Pestano, David Serwadda, Alfred M. Prince, Donna Pascual, Nelson K. Sewankambo, William Boto	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact